XPO CapEx increased by 4.7% to $111.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 44.2%, from $199.00M to $111.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 25.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $61.00M | $77.00M | $57.00M | $123.00M | $119.00M | $112.00M | $167.00M | $224.00M | $131.00M | $139.00M | $1.04B | $306.00M | $190.00M | $127.00M | $166.00M | $199.00M | $196.00M | $156.00M | $106.00M | $111.00M |
| QoQ Change | — | +26.2% | -26.0% | +115.8% | -3.3% | -5.9% | +49.1% | +34.1% | -41.5% | +6.1% | +647.5% | -70.5% | -37.9% | -33.2% | +30.7% | +19.9% | -1.5% | -20.4% | -32.1% | +4.7% |
| YoY Change | — | — | — | — | +95.1% | +45.5% | +193.0% | +82.1% | +10.1% | +24.1% | +522.2% | +36.6% | +45.0% | -8.6% | -84.0% | -35.0% | +3.2% | +22.8% | -36.1% | -44.2% |